Company intelligence / Profile preview

Paratus Investment

New York, New York, United Stateszoominfo.com ↗

Ownership: Private
Development stage: Other

Overview

Paratus Sciences is a preclinical-stage biotechnology company developing a drug discovery platform inspired by the unique biology of bats. The company's initial focus is on identifying new therapeutic targets for inflammation and cardiometabolic conditions, with potential expansion into oncology and aging. No clinical results have been reported as of June 2025; the pipeline remains in early discovery.

Therapeutic areas: OtherOncologyImmunologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Academic collaborations with National University of Singapore, MIT, Mount Sinai Health System

Beyond the preview

Go deeper on Paratus Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paratus Investment.

Explore the full profile